SI-BONE

SI-BONE, Inc. is a medical device company based in Santa Clara, California, founded in 2008. The company specializes in surgical solutions for musculoskeletal disorders, particularly focusing on the sacroiliac (SI) joint. SI-BONE is known for its iFuse Implant System®, a minimally invasive technology designed to fuse the SI joint and address dysfunction that can lead to chronic lower back pain. The iFuse Implant System® features a unique triangular design for immediate stabilization and a 3D-printed porous surface that encourages bone growth into the implant, improving long-term outcomes. SI-BONE has also developed the iFuse-3D™, which has received regulatory clearance for additional uses, including pelvic trauma and adult spinal deformity. Their products are utilized by trained surgeons globally to treat various conditions related to SI joint dysfunction. In addition to its innovative products, SI-BONE offers physician training programs and forms strategic partnerships to enhance market reach and surgical outcomes. The company has achieved significant milestones, including FDA approval for its flagship product and a successful IPO in 2018. SI-BONE reported revenues of $146.7 million in 2024, indicating strong growth in the medical device market.

• Employees 350
• Founded 2008
• Annual Revenue $167178000
• Total Funding $364199999